The metabolism of fenclofenac in the horse.

This study explores how a drug called fenclofenac is metabolized in horses, finding that it is quickly absorbed and eliminated, with the majority of it being converted into an ester glucuronide in the horse’s body.

Introduction

The study sets out to explore the metabolism of fenclofenac, a non-steroidal anti-inflammatory drug, and its metabolites in the horses. The research is significant as it’s the first to highlight that an ester glucuronide serves as a primary metabolite for a non-steroidal anti-inflammatory drug in horses. Knowing how drugs metabolize in horses is crucial for understanding their effects and optimizing their use.

Method and Results

• Fenclofenac labeled with radioactive carbon-14 (14C-Fenclofenac) was administered orally to the horses, which allows for the tracking of the drug and its metabolites.
• Urinary metabolites, or the products of fenclofenac metabolism within the body, were then investigated using chromatography techniques.
• Fenclofenac was found to be rapidly absorbed and eliminated by the horses’ bodies, with a plasma half-life of just 2.3 hours. A half-life is the time it takes for half of a substance to be eliminated from the body.
• Between 83.2 and 85.8% of the administrated dose was recovered in the urine within a 24-hour period – this suggests that fenclofenac is primarily processed and excreted through the kidneys.
• The major urinary metabolite found was the ester glucuronide of fenclofenac, accounting for between 58.8 and 70% of the dose. An ester glucuronide is a molecule formed by joining the drug molecule and glucuronic acid. This joined molecule is easier for the body to excrete than the original drug molecule.
• The study also suggests that this ester glucuronide metabolite undergoes a structural rearrangement to form isomers that are resistant to an enzyme known as beta-glucuronidase.
• Other components detected in the horses’ urine were unchanged fenclofenac, accounting for between 13.1 and 11.5% of the dose, along with two minor metabolites including a monohydroxy fenclofenac.

Conclusion

This research advances our understanding of how horses metabolize fenclofenac, a non-steroidal anti-inflammatory drug. The finding that an ester glucuronide is the primary metabolite in horses is a novel contribution, emphasizing the complexity of drug metabolism in these animals. Understanding these processes can help in predicting the behavior of similar drugs within the body and inform better veterinary pharmaceutical practices.